Related references
Note: Only part of the references are listed.Partial Agonists of the α3β4*Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats
Susmita Chatterjee et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
Mehmet Sofuoglu
ADDICTION (2010)
The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
Eoin C. O'Connor et al.
PSYCHOPHARMACOLOGY (2010)
Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition
Hans Rollema et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Varenicline Improves Mood and Cognition During Smoking Abstinence
Freda Patterson et al.
BIOLOGICAL PSYCHIATRY (2009)
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
Sherry A. McKee et al.
BIOLOGICAL PSYCHIATRY (2009)
The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System
Mia Ericson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The influence of mecamylamine on ethanol and sucrose self-administration
Matthew M. Ford et al.
NEUROPHARMACOLOGY (2009)
Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice
Linzy M. Hendrickson et al.
PSYCHOPHARMACOLOGY (2009)
Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats
Leontien Diergaarde et al.
BIOLOGICAL PSYCHIATRY (2008)
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice
Danielle Gulick et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues
Elin Lof et al.
PSYCHOPHARMACOLOGY (2007)
Varenicline, an α402 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
Pia Steensland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers
Suchitra Krishnan-Sarin et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test
Mark Day et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control
Tommy Pattij et al.
PSYCHOPHARMACOLOGY (2007)
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
H. Rollema et al.
NEUROPHARMACOLOGY (2007)
Smoking cessation efficacy and safety of varenicline, an α4β2 nicotinic receptor partial agonist
Serena Tonstad
JOURNAL OF CARDIOVASCULAR NURSING (2006)
Alcohol, neurotransmitter systems, and behavior
Garvin Chastain
JOURNAL OF GENERAL PSYCHOLOGY (2006)
Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol
Elisabet Jerlhag et al.
ALCOHOL AND ALCOHOLISM (2006)
Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors
Karla B. Mihalak et al.
MOLECULAR PHARMACOLOGY (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of maintenance therapy with varenicline on smoking cessation - A randomized controlled trial
Serena Tonstad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Behavioral disinhibition requires dopamine receptor activation
Marcel M. van Gaalen et al.
PSYCHOPHARMACOLOGY (2006)
Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial
RF Anton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of a novel nicotinic receptor antagonist, N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats
NM Neugebauer et al.
PSYCHOPHARMACOLOGY (2006)
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization
ED Levin et al.
PSYCHOPHARMACOLOGY (2006)
Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance
JJ Buccafusco et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
JW Coe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Neuropsychological functioning and alcohol dependence
A Scheurich
CURRENT OPINION IN PSYCHIATRY (2005)
Is an α-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol?
A Larsson et al.
ALCOHOL (2004)
The reinstatement model of drug relapse: history, methodology and major findings
Y Shaham et al.
PSYCHOPHARMACOLOGY (2003)
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
TW Robbins
PSYCHOPHARMACOLOGY (2002)
Neurobiology of relapse to alcohol in rats
AD Lê et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol
B Söderpalm et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies
A Blondel et al.
PSYCHOPHARMACOLOGY (2000)
Peripheral involvement in nicotine-induced enhancement of ethanol intake
M Ericson et al.
ALCOHOL (2000)